SPOTLIGHT -
Chicago-An investigation of human amniotic membrane (HAM) patch grafts indicates that these transplants can be used as an alternative to therapeutic keratoplasty in selected
Ocugen completes dosing of subjects with geographic atrophy in Cohort 2 of Phase 1/2 ArMaDa clinical trial of OCU410
(EyePod) From idea to impact: Navigating ophthalmic innovation
Intracortical Visual Prosthesis achieves 2 years of successful testing
EyePod: Modifier Gene Therapy: What is it?
Using extracellular vesicles in the treatment of ocular diseases
Ocular Therapeutix announces positive topline Phase 1 data for Axpaxli in diabetic retinopathy